Teva Pharmaceutical Industries (TEVA) Enterprise Value (QoQ) (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) Enterprise Value (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.21% |
| Dec 31, 2025 | -61.53% |
| Sep 30, 2025 | -2.09% |
| Jun 30, 2025 | -27.46% |
| Mar 31, 2025 | 42.91% |
| Dec 31, 2024 | 1.33% |
| Sep 30, 2024 | -46.06% |
| Jun 30, 2024 | 24.65% |
| Mar 31, 2024 | -4.60% |
| Dec 31, 2023 | -56.33% |
| Sep 30, 2023 | 17.19% |
| Jun 30, 2023 | -44.61% |
| Mar 31, 2023 | 30.64% |
| Dec 31, 2022 | -36.16% |
| Sep 30, 2022 | -16.34% |
| Jun 30, 2022 | -0.64% |
| Mar 31, 2022 | -5.00% |
| Dec 31, 2021 | -13.01% |
| Sep 30, 2021 | 26.78% |
| Jun 30, 2021 | -88.67% |